Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James A Underberg

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|September 10, 2014
Lack of pharmacokinetic interactions between pitavastatin and efavirenz or darunavir/ritonavirCarlos D Malvestutto, Qing Ma, Gene D Morse, et al.
Journal of Clinical Lipidology|October 7, 2020
Long-term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia: Five-year data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER)James A Underberg, Christopher P Cannon, Dominique Larrey, et al.
Journal of Clinical Lipidology|June 19, 2021
JCL Roundtable: Global Think Tank on Lipoprotein(a)Lisa L Maher, S Lale Tokgözoğlu, Eduardo J Sanchez, et al.
Clinical Cardiology|March 23, 2017
PCSK9 inhibitor access barriers-issues and recommendations: Improving the access process for patients, clinicians and payersSeth J Baum, Peter P Toth, James A Underberg, et al.
Current Diabetes Reports|November 25, 2010
Resistant hypertension and sleep apnea: pathophysiologic insights and strategic managementStephen K Williams, Joseph Ravenell, Girardin Jean-Louis, et al.
Journal of Clinical Lipidology|May 24, 2017
Update on the use of PCSK9 inhibitors in adults: Recommendations from an Expert Panel of the National Lipid AssociationCarl E Orringer, Terry A Jacobson, Joseph J Saseen, et al.
Atherosclerosis|September 21, 2014
Laparoscopic gastric banding resolves the metabolic syndrome and improves lipid profile over five years in obese patients with body mass index 30-40 kg/m(2.)Sean P Heffron, Amita Singh, Jonathan Zagzag, et al.
Cardiology|May 13, 2019
Cardiovascular Risk Factor Control and Lifestyle Factors in Young to Middle-Aged Adults with Newly Diagnosed Obstructive Coronary Artery DiseaseMichael S Garshick, Georgeta D Vaidean, Anish Vani, et al.
Journal of the American College of Cardiology|August 20, 2016
Cardiovascular Effects of the New Weight Loss AgentsMatthew H Vorsanger, Pritha Subramanyam, Howard S Weintraub, et al.
Journal of Clinical Lipidology|June 9, 2020
Genetic testing in dyslipidemia: A scientific statement from the National Lipid AssociationEmily E Brown, Amy C Sturm, Marina Cuchel, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Acquired Immune Deficiency Syndromes (1999)|September 10, 2014
Lack of pharmacokinetic interactions between pitavastatin and efavirenz or darunavir/ritonavirCarlos D Malvestutto, Qing Ma, Gene D Morse, et al.
Journal of Clinical Lipidology|October 7, 2020
Long-term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia: Five-year data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER)James A Underberg, Christopher P Cannon, Dominique Larrey, et al.
Journal of Clinical Lipidology|June 19, 2021
JCL Roundtable: Global Think Tank on Lipoprotein(a)Lisa L Maher, S Lale Tokgözoğlu, Eduardo J Sanchez, et al.
Clinical Cardiology|March 23, 2017
PCSK9 inhibitor access barriers-issues and recommendations: Improving the access process for patients, clinicians and payersSeth J Baum, Peter P Toth, James A Underberg, et al.
Current Diabetes Reports|November 25, 2010
Resistant hypertension and sleep apnea: pathophysiologic insights and strategic managementStephen K Williams, Joseph Ravenell, Girardin Jean-Louis, et al.
Journal of Clinical Lipidology|May 24, 2017
Update on the use of PCSK9 inhibitors in adults: Recommendations from an Expert Panel of the National Lipid AssociationCarl E Orringer, Terry A Jacobson, Joseph J Saseen, et al.
Atherosclerosis|September 21, 2014
Laparoscopic gastric banding resolves the metabolic syndrome and improves lipid profile over five years in obese patients with body mass index 30-40 kg/m(2.)Sean P Heffron, Amita Singh, Jonathan Zagzag, et al.
Cardiology|May 13, 2019
Cardiovascular Risk Factor Control and Lifestyle Factors in Young to Middle-Aged Adults with Newly Diagnosed Obstructive Coronary Artery DiseaseMichael S Garshick, Georgeta D Vaidean, Anish Vani, et al.
Journal of the American College of Cardiology|August 20, 2016
Cardiovascular Effects of the New Weight Loss AgentsMatthew H Vorsanger, Pritha Subramanyam, Howard S Weintraub, et al.
Journal of Clinical Lipidology|June 9, 2020
Genetic testing in dyslipidemia: A scientific statement from the National Lipid AssociationEmily E Brown, Amy C Sturm, Marina Cuchel, et al.
Pageof 3